Skip to main content
. 2016 Apr 11;7(22):32532–32542. doi: 10.18632/oncotarget.8687

Table 3. Drug-related AEs.

Number of patients (%) n = 44
Drug-related event Any grade Grade ≥ 3
Any 39 (89) 10 (23)
Total number of AEs 151 13
Infusion-related reactions 28 (64) 0
Pyrexia 14 (32) 0
Headache 7 (16) 0
Coombs indirect test positive 4 (9) 0
Asthenia 4 (9) 2 (5)
Nausea 4 (9) 0
Increased alanine aminotransferase 3 (7) 2 (5)
Vomiting 3 (7) 0
Abdominal pain 2 (5) 0
Increased blood bilirubin 2 (5) 1 (2)
Decreased appetite 2 (5) 0
Fatigue 2 (5) 0
Constipation 2 (5) 0
Rash 2 (5) 0
Aseptic meningitis 2 (5) 2 (5)

Abbreviation: AE, adverse event.

Included are drug-related AEs that occurred in at least 2 patients. The other related AEs of grade ≥3 were increased blood lactate dehydrogenase, febrile neutropenia, hemolysis, neutropenia, tumor lysis syndrome, and decreased white blood cell count experienced by 1 patient each (2%).